Home › Funds › Siren, L.L.C. › CRNX

Siren, L.L.C. position in CRNX

CRINETICS PHARMACEUTICALS IN

Siren, L.L.C. reported holding 1,420,788 shares of CRNX (CRINETICS PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$53.2M, representing 1.08% of its reported portfolio and ranking #30 among its reported holdings. Siren, L.L.C. has disclosed CRNX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)1.42M sh
Reported value held$53.17M
Portfolio Weight1.08%
First reportedQ3 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s CRNX position evolved

Siren, L.L.C. first disclosed a stake in CRNX in Q3 2024 at 1,309,652 shares (US$66.9M). The position peaked in Q4 2024 at 1,609,652 shares, worth US$82.3M. Across 8 filings, Siren, L.L.C. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 1,420,788 shares valued at US$53.2M — a reduction of -482,848 shares quarter over quarter.. Notable position changes include a 26% increase in Q1 2026, a 25% trim in Q2 2026.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.31M $66.92M New
Q4 2024 1.61M $82.30M Add
Q1 2025 1.69M $56.64M Add
Q2 2025 1.69M $48.56M Hold
Q3 2025 1.69M $70.33M Hold
Q4 2025 1.51M $70.18M Reduce
Q1 2026 1.90M $69.14M Add
Q2 2026 1.42M $53.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRNX and 13F data

CRNX (CRINETICS PHARMACEUTICALS IN) is a company whose sector is not yet classified in our data. 37 other funds we track also report a position in CRNX — the largest reported positions include Farallon Capital Management (US$336.4M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$336.4M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$241.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRNX

All CRNX fund holders →

FAQ

How long has Siren, L.L.C. held CRNX?

Siren, L.L.C. has disclosed CRNX holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Siren, L.L.C.'s current position in CRNX?

As of Q2 2026, Siren, L.L.C. holds 1.42M shares of CRNX (CRINETICS PHARMACEUTICALS IN), valued at $53.17M, representing 1.08% of its reported portfolio and ranking #30.

Has Siren, L.L.C. been buying or selling CRNX?

In the latest 13F filing (Q2 2026), Siren, L.L.C. reduced its position in CRNX. The position peaked in Q4 2024 at 1.61M shares.

Which other funds hold CRNX?

Other major institutional holders of CRNX include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.